SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001104659-20-022899
Filing Date
2020-02-19
Accepted
2020-02-19 17:22:04
Documents
2
Period of Report
2020-02-14

Document Format Files

Seq Description Document Type Size
1 4 a4.html 4  
1 4 a4.xml 4 7199
2 EX-24 ex-24.htm EX-24 10165
  Complete submission text file 0001104659-20-022899.txt   18694
Mailing Address 555 LONG WHARF DRIVE NEW HAVEN CT 06511
Business Address 555 LONG WHARF DRIVE NEW HAVEN CT 06511 203-643-8060
BioXcel Therapeutics, Inc. (Issuer) CIK: 0001720893 (see all company filings)

IRS No.: 821386754 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 780 EAST MAIN STREET C/O BIOXCEL THERAPEUTICS, INC. BRANFORD CT 06405
Business Address
Yocca Frank (Reporting) CIK: 0001733272 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-38410 | Film No.: 20631211